The app for independent voices

Thomas Wolff's avatar
Thomas Wolff Apr 30, 2024
PRISM MediaWire - News and Media Service

$BSEM BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts

newsroom.prismmediawire.com

BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts

POMPANO BEACH, FLORIDA, April 30, 2024 - PRISM MediaWire - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived tissue allografts for advanced wound care, today ...

Apr 30, 2024
at
1:20 PM

Log in or sign up

Join the most interesting and insightful discussions.